Optimal Conservative Therapy Use among Adult Cure Glomerulonephropathy Participants with IgA Nephropathy

Arun Rajasekaran, Maria Larkina, Bruce A. Julian, Pietro A. Canetta, Bethany A. Roehm, Myda Khalid, Laura H. Mariani, Dana V. Rizk

Open source

DOI
10.34067/kid.0000000000000306
Published
2023-11-14
Container
Kidney360
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.34067/kid.0000000000000306,
  title = {Optimal Conservative Therapy Use among Adult Cure Glomerulonephropathy Participants with IgA Nephropathy},
  author = {Arun Rajasekaran and Maria Larkina and Bruce A. Julian and Pietro A. Canetta and Bethany A. Roehm and Myda Khalid and Laura H. Mariani and Dana V. Rizk},
  year = {2023},
  journal = {Kidney360},
  doi = {10.34067/kid.0000000000000306},
  url = {https://doi.org/10.34067/kid.0000000000000306}
}

RIS

TY  - JOUR
TI  - Optimal Conservative Therapy Use among Adult Cure Glomerulonephropathy Participants with IgA Nephropathy
AU  - Arun Rajasekaran
AU  - Maria Larkina
AU  - Bruce A. Julian
AU  - Pietro A. Canetta
AU  - Bethany A. Roehm
AU  - Myda Khalid
AU  - Laura H. Mariani
AU  - Dana V. Rizk
PY  - 2023
JO  - Kidney360
DO  - 10.34067/kid.0000000000000306
UR  - https://doi.org/10.34067/kid.0000000000000306
ER  - 

APA

Rajasekaran, A., Larkina, M., Julian, B. A., Canetta, P. A., Roehm, B. A., Khalid, M., Mariani, L. H., & Rizk, D. V. (2023). Optimal Conservative Therapy Use among Adult Cure Glomerulonephropathy Participants with IgA Nephropathy. Kidney360. https://doi.org/10.34067/kid.0000000000000306

Source records